These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15958182)

  • 21. Correcting false gene expression measurements from degraded RNA using RTQ-PCR.
    Port M; Schmelz HU; Stassen T; Müeller K; Stockinger M; Obermair R; Abend M
    Diagn Mol Pathol; 2007 Mar; 16(1):38-49. PubMed ID: 17471157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
    Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
    Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
    Fabjani G; Tong D; Wolf A; Roka S; Leodolter S; Hoecker P; Fischer MB; Jakesz R; Zeillinger R
    Oncol Rep; 2005 Sep; 14(3):737-41. PubMed ID: 16077985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The optimization of quantitative reverse transcription PCR for verification of cDNA microarray data.
    Hembruff SL; Villeneuve DJ; Parissenti AM
    Anal Biochem; 2005 Oct; 345(2):237-49. PubMed ID: 16139235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of messenger RNA abundance for ribosomal protein L-15, cyclophilin-A, phosphoglycerokinase, beta-glucuronidase, glyceraldehyde 3-phosphate dehydrogenase, beta-actin, and histone H2A during bovine oocyte maturation and early embryogenesis in vitro.
    Bettegowda A; Patel OV; Ireland JJ; Smith GW
    Mol Reprod Dev; 2006 Mar; 73(3):267-78. PubMed ID: 16261607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR.
    Fleige S; Walf V; Huch S; Prgomet C; Sehm J; Pfaffl MW
    Biotechnol Lett; 2006 Oct; 28(19):1601-13. PubMed ID: 16900335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of cell culture, RNA extraction, and reverse transcription to the measurement error in quantitative reverse transcription polymerase chain reaction-based gene expression quantification.
    Combes JD; Grelier G; Laversanne M; Voirin N; Chabaud S; Ecochard R; Lasset C; Moyret-Lalle C
    Anal Biochem; 2009 Oct; 393(1):29-35. PubMed ID: 19527676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
    Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
    Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
    Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
    Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer.
    Mecklenburg I; Weckermann D; Zippelius A; Schoberth A; Petersen S; Prang N; Riethmüller G; Kufer P
    J Immunol Methods; 2007 Jun; 323(2):180-93. PubMed ID: 17540401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new method of competitive reverse transcription polymerase chain reaction with SYBR Gold staining for quantitative analysis of mRNA.
    Oba R; Kudo Y; Sato N; Noda R; Otsuka Y
    Electrophoresis; 2006 Jul; 27(14):2865-8. PubMed ID: 16688698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of internal control for gene expression studies in equine tissues and cell culture using quantitative RT-PCR.
    Zhang YW; Davis EG; Bai J
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):114-9. PubMed ID: 19269038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of breast cancer cell lines by a low-density microarray.
    de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
    Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.
    Meijer D; Jansen MP; Look MP; Ruigrok-Ritstier K; van Staveren IL; Sieuwerts AM; van Agthoven T; Foekens JA; Dorssers LC; Berns EM
    Breast Cancer Res Treat; 2009 Jan; 113(2):253-60. PubMed ID: 18299979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
    Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.
    Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Hara Y; Kobayashi S; Iwase H
    Breast Cancer Res Treat; 2005 Nov; 94(1):11-6. PubMed ID: 16172792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
    Loo WT; Chen JP; Chow LW; Chou JW
    Biomed Pharmacother; 2007 Oct; 61(9):601-5. PubMed ID: 17913446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.